Shopping Cart
- Remove All
- Your shopping cart is currently empty
SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $68 | In Stock | |
10 mg | $118 | In Stock | |
25 mg | $247 | In Stock | |
50 mg | $392 | In Stock | |
100 mg | $588 | In Stock |
Description | SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research. |
Targets&IC50 | SIRT2:1.3 μM |
In vitro | SIRT2-IN-9 (1-100 μM; 15 min) dose-dependently inhibits SIRT2 (IC50=1.3 μM) while also inhibiting SIRT1 and SIRT3 (IC50s >300 μM).[1] Additionally, SIRT2-IN-9 (0-50 μM; 72 h) affects the cell viability and dose-dependently inhibits the proliferation of MCF-7 breast cancer cells.[1] SIRT2-IN-9 (0-50 μM; 6 h) also impacts the acetylation of α-tubulin protein.[1] |
Molecular Weight | 438.57 |
Formula | C21H22N6OS2 |
Cas No. | 522650-91-5 |
Smiles | CCCn1c2ccccc2c2nnc(SCC(=O)Nc3nc4CCCCc4s3)nc12 |
Storage | Shipping with blue ice. | |||||||||||||||
Solubility Information | DMSO: 4.0 mg/mL (9.2 mM), Sonication and heating to 70℃ are recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.